FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313070028> ?p ?o ?g. }

• W4313070028 abstract "Idiopathic pulmonary fibrosis (IPF) represents a progressive interstitial lung disease with a mean survival time of 3-5 years. Approved pharmacological therapies may slow down, but not stop disease progression. IPF pathogenesis is characterized by the deposition of excessive amounts of fibrotic extracellular matrix of activated myofibroblasts resulting in a loss of lung function. We developed a phenotypic drug discovery assay measuring fibrotic ECM deposition by primary human lung fibroblasts (pHLFs) derived from IPF patients treated with transforming growth factor beta 1 (TGFβ1) and drug compounds. 1509 small molecule compounds were screened for the inhibition of TGFβ1-induced ECM deposition. Deep learning-based image analysis identified 31 hit compounds. Based on the hit Tranilast with a significant inhibitory activity on TGFβ1-induced fibroblast-myofibroblast-transdifferentiation and ECM deposition, structure-activity-relationship studies discovered a group of novel highly potent cinnamic acid amides, in particular N-(2-butoxyphenyl)-3-(phenyl)acrylamides and N-(2-benzoxyphenyl)-3-(phenyl)acrylamides (N23Ps). N23Ps showed high potency for the inhibition of TGFβ1 dependent αSMA induction and ECM deposition. Transcriptomic and proteomic analysis showed N23Ps to inhibit specific fibrotic signatures in TGFβ1-treated pHLFs as well as in a human ex vivo injury and early 3D fibrosis model using human precision cut lung slice tissue cultures (PCLS). RNA interference rescue experiments showed inhibition of TGFβ1 signaling by N23Ps to be SMURF2-dependent. Local pulmonary application of N23P significantly inhibited bleomycin-induced lung function decline in a murine bleomycin-induced lung fibrosis model." @default.
• W4313070028 created "2023-01-06" @default.
• W4313070028 creator A5002353324 @default.
• W4313070028 creator A5004941651 @default.
• W4313070028 creator A5005466117 @default.
• W4313070028 creator A5007385561 @default.
• W4313070028 creator A5009672774 @default.
• W4313070028 creator A5011253452 @default.
• W4313070028 creator A5014631735 @default.
• W4313070028 creator A5016601141 @default.
• W4313070028 creator A5017736098 @default.
• W4313070028 creator A5018756235 @default.
• W4313070028 creator A5020337468 @default.
• W4313070028 creator A5021815844 @default.
• W4313070028 creator A5022603365 @default.
• W4313070028 creator A5025441654 @default.
• W4313070028 creator A5029335660 @default.
• W4313070028 creator A5030292487 @default.
• W4313070028 creator A5032022921 @default.
• W4313070028 creator A5034569250 @default.
• W4313070028 creator A5038873686 @default.
• W4313070028 creator A5053293174 @default.
• W4313070028 creator A5062406127 @default.
• W4313070028 creator A5064967221 @default.
• W4313070028 creator A5067697875 @default.
• W4313070028 creator A5072287527 @default.
• W4313070028 creator A5073200002 @default.
• W4313070028 creator A5076880767 @default.
• W4313070028 creator A5078261997 @default.
• W4313070028 creator A5086970985 @default.
• W4313070028 creator A5088399987 @default.
• W4313070028 creator A5089465333 @default.
• W4313070028 date "2022-09-04" @default.
• W4313070028 modified "2023-10-17" @default.
• W4313070028 title "Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics" @default.
• W4313070028 doi "https://doi.org/10.1183/13993003.congress-2022.1028" @default.
• W4313070028 hasPublicationYear "2022" @default.
• W4313070028 type Work @default.
• W4313070028 citedByCount "0" @default.
• W4313070028 crossrefType "proceedings-article" @default.
• W4313070028 hasAuthorship W4313070028A5002353324 @default.
• W4313070028 hasAuthorship W4313070028A5004941651 @default.
• W4313070028 hasAuthorship W4313070028A5005466117 @default.
• W4313070028 hasAuthorship W4313070028A5007385561 @default.
• W4313070028 hasAuthorship W4313070028A5009672774 @default.
• W4313070028 hasAuthorship W4313070028A5011253452 @default.
• W4313070028 hasAuthorship W4313070028A5014631735 @default.
• W4313070028 hasAuthorship W4313070028A5016601141 @default.
• W4313070028 hasAuthorship W4313070028A5017736098 @default.
• W4313070028 hasAuthorship W4313070028A5018756235 @default.
• W4313070028 hasAuthorship W4313070028A5020337468 @default.
• W4313070028 hasAuthorship W4313070028A5021815844 @default.
• W4313070028 hasAuthorship W4313070028A5022603365 @default.
• W4313070028 hasAuthorship W4313070028A5025441654 @default.
• W4313070028 hasAuthorship W4313070028A5029335660 @default.
• W4313070028 hasAuthorship W4313070028A5030292487 @default.
• W4313070028 hasAuthorship W4313070028A5032022921 @default.
• W4313070028 hasAuthorship W4313070028A5034569250 @default.
• W4313070028 hasAuthorship W4313070028A5038873686 @default.
• W4313070028 hasAuthorship W4313070028A5053293174 @default.
• W4313070028 hasAuthorship W4313070028A5062406127 @default.
• W4313070028 hasAuthorship W4313070028A5064967221 @default.
• W4313070028 hasAuthorship W4313070028A5067697875 @default.
• W4313070028 hasAuthorship W4313070028A5072287527 @default.
• W4313070028 hasAuthorship W4313070028A5073200002 @default.
• W4313070028 hasAuthorship W4313070028A5076880767 @default.
• W4313070028 hasAuthorship W4313070028A5078261997 @default.
• W4313070028 hasAuthorship W4313070028A5086970985 @default.
• W4313070028 hasAuthorship W4313070028A5088399987 @default.
• W4313070028 hasAuthorship W4313070028A5089465333 @default.
• W4313070028 hasBestOaLocation W43130700282 @default.
• W4313070028 hasConcept C118131993 @default.
• W4313070028 hasConcept C126322002 @default.
• W4313070028 hasConcept C142724271 @default.
• W4313070028 hasConcept C189165786 @default.
• W4313070028 hasConcept C207865475 @default.
• W4313070028 hasConcept C2776232574 @default.
• W4313070028 hasConcept C2776694085 @default.
• W4313070028 hasConcept C2777714996 @default.
• W4313070028 hasConcept C2778341716 @default.
• W4313070028 hasConcept C2780559512 @default.
• W4313070028 hasConcept C2781244666 @default.
• W4313070028 hasConcept C502942594 @default.
• W4313070028 hasConcept C71924100 @default.
• W4313070028 hasConcept C86803240 @default.
• W4313070028 hasConcept C95444343 @default.
• W4313070028 hasConcept C98274493 @default.
• W4313070028 hasConceptScore W4313070028C118131993 @default.
• W4313070028 hasConceptScore W4313070028C126322002 @default.
• W4313070028 hasConceptScore W4313070028C142724271 @default.
• W4313070028 hasConceptScore W4313070028C189165786 @default.
• W4313070028 hasConceptScore W4313070028C207865475 @default.
• W4313070028 hasConceptScore W4313070028C2776232574 @default.
• W4313070028 hasConceptScore W4313070028C2776694085 @default.
• W4313070028 hasConceptScore W4313070028C2777714996 @default.
• W4313070028 hasConceptScore W4313070028C2778341716 @default.
• W4313070028 hasConceptScore W4313070028C2780559512 @default.
• W4313070028 hasConceptScore W4313070028C2781244666 @default.
• W4313070028 hasConceptScore W4313070028C502942594 @default.
• W4313070028 hasConceptScore W4313070028C71924100 @default.

• next